Nivolumab combined with radiotherapy with or without temozolomide in patients with newly diagnosed gioblastoma: Results from phase 1 safety cohorts in CheckMate 143 Meeting Abstract
| Authors: | Omuro, A.; Vlahovic, G.; Baehring, J.; Butowski, N. A.; Reardon, D. A.; Cloughesy, T.; Sahebjam, S.; Lim, M.; Strauss, L.; Latek, R.; Zwirtes, R.; Paliwal, P.; Harbison, C.; Sampson, J. |
| Abstract Title: | Nivolumab combined with radiotherapy with or without temozolomide in patients with newly diagnosed gioblastoma: Results from phase 1 safety cohorts in CheckMate 143 |
| Meeting Title: | 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 18 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Nov 17-20 |
| Meeting Location: | Scottsdale, AZ |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-11-01 |
| Start Page: | vi21 |
| Language: | English |
| ACCESSION: | WOS:000398604101017 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/now212.081 |
| Notes: | Meeting Abstract: ATIM-16 -- Source: Wos |
